Active Pharmaceutical Ingredient (API)

Emicizumab

Bispecific Monoclonal Antibody

A humanized bispecific antibody that bridges activated factor IX and factor X, effectively mimicking the function of the missing activated factor VIII. It is a revolutionary treatment for Hemophilia A, especially for patients with inhibitors.
Technical Profile
Reference Code
EMI832
CAS Number
1610943-06-0
Chemical Class
N/A
Therapeutic Class
N/A

Verified Brands

Medicines containing Emicizumab as an active ingredient.

Brand Name Manufacturer Formulation MRP
No verified brands found for this salt.